These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 24885121)
1. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge. Zhang F; Hao C; Zhang S; Li A; Zhang Q; Wu W; Liu L; Li C; Liang M; Li X; Li D Virol J; 2014 May; 11():80. PubMed ID: 24885121 [TBL] [Abstract][Full Text] [Related]
2. [Study on adjuvant effect of oral recombinant subunit vaccine formulated with chitosan against human enterovirus 71]. Zhang S; Zhang FS; Li AQ; Liu L; Wu W; Li C; Zhang QF; Liang MF; Li DX Bing Du Xue Bao; 2014 May; 30(3):221-5. PubMed ID: 25118374 [TBL] [Abstract][Full Text] [Related]
3. Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice. Li YX; Zhao H; Cao RY; Deng YQ; Han JF; Zhu SY; Ma J; Liu L; Qin ED; Qin CF Virol J; 2014 May; 11():79. PubMed ID: 24885030 [TBL] [Abstract][Full Text] [Related]
4. Production of EV71 vaccine candidates. Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566 [TBL] [Abstract][Full Text] [Related]
5. VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment. Chen FH; Liu X; Fang HL; Nan N; Li Z; Ning NZ; Luo DY; Li T; Wang H Front Immunol; 2019; 10():2564. PubMed ID: 31787970 [TBL] [Abstract][Full Text] [Related]
6. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71. Yu Z; Huang Z; Sao C; Huang Y; Zhang F; Ma G; Chen Z; Zeng Z; Qiwen D; Zeng W Arch Virol; 2013 May; 158(5):1071-7. PubMed ID: 23275129 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice. Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453 [TBL] [Abstract][Full Text] [Related]
8. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71. Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164 [TBL] [Abstract][Full Text] [Related]
9. Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection. Kim YI; Song JH; Kwon BE; Kim HN; Seo MD; Park K; Lee S; Yeo SG; Kweon MN; Ko HJ; Chang SY Vaccine; 2015 Nov; 33(48):6604-10. PubMed ID: 26529069 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model. Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344 [TBL] [Abstract][Full Text] [Related]
11. Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice. Premanand B; Prabakaran M; Kiener TK; Kwang J PLoS One; 2013; 8(2):e55536. PubMed ID: 23390538 [TBL] [Abstract][Full Text] [Related]
12. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Xu L; He D; Li Z; Zheng J; Yang L; Yu M; Yu H; Chen Y; Que Y; Shih JW; Liu G; Zhang J; Zhao Q; Cheng T; Xia N Theranostics; 2014; 4(5):498-513. PubMed ID: 24669278 [TBL] [Abstract][Full Text] [Related]
13. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the enterovirus 71 VP1 protein as a vaccine candidate. Zhou SL; Ying XL; Han X; Sun XX; Jin Q; Yang F J Med Virol; 2015 Feb; 87(2):256-62. PubMed ID: 25043151 [TBL] [Abstract][Full Text] [Related]
15. Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice. Xu P; Wang Y; Tao L; Wu X; Wu W Biotechnol Lett; 2019 Jul; 41(6-7):867-872. PubMed ID: 31119429 [TBL] [Abstract][Full Text] [Related]
16. Development of enhanced antibody response toward dual delivery of nano-adjuvant adsorbed human Enterovirus-71 vaccine encapsulated carrier. Saeed MI; Omar AR; Hussein MZ; Elkhidir IM; Sekawi Z Hum Vaccin Immunother; 2015; 11(10):2414-24. PubMed ID: 26186664 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine. Han X; Ying XL; Zhou SL; Han T; Huang H; Jin Q; Yang F; Sun QY; Sun XX Hum Vaccin Immunother; 2014; 10(8):2220-6. PubMed ID: 25424925 [TBL] [Abstract][Full Text] [Related]
18. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Wu CN; Lin YC; Fann C; Liao NS; Shih SR; Ho MS Vaccine; 2001 Dec; 20(5-6):895-904. PubMed ID: 11738755 [TBL] [Abstract][Full Text] [Related]
19. Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine. Lin YL; Cheng PY; Chin CL; Huang LM; Lin SY; Chiang BL Vaccine; 2018 Jul; 36(29):4331-4338. PubMed ID: 29891349 [TBL] [Abstract][Full Text] [Related]
20. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice. Wang M; Jiang S; Wang Y Biochem Biophys Res Commun; 2013 Jan; 430(1):387-93. PubMed ID: 23159634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]